Evidence Synthesis
ZIMLAB posted a strong quarterly earnings report, with its gross margin accelerating to 53.03%, up from -3.1%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:13
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
ZIMLAB posted a strong quarterly earnings report, with its gross margin accelerating to 53.03%, up from -3.1%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.03 % | -3.1 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -3.1 % | 0.93 | ▼ |
| REVENUE_GROWTH_YOY | 31.2 % | — | - |
| PRICE_CHANGE_PERCENT | -1.968 % | — | - |
| DAILY_VOLUME | 54,799 shares | 69,212 | ▼ |
| CLOSE_PRICE | 125.5 INR | 128.02 | ▼ |